RT Journal Article
T1 Nephron-sparing surgery for adenocarcinoma in a renal allograft.
A1 Vázquez Alonso, Fernando
A1 Cardozo Rodríguez, Enrique
A1 Puche Sanz, Ignacio
A1 Flores Martin, Jose Francisco
A1 Molina Hernandez, Jose Miguel
A1 Berrio Campos, Raquel
A1 Vicente Prados, Javier
A1 Medina Benitez, Antonio
A1 Cózar Olmo, Jose Manuel
K1 Neoplasias Renales
K1 Trasplante de Riñón
K1 Nefrectomía
K1 Femenino
K1 Trasplante Homólogo
K1 Carcinoma de Células Renales
K1 Resultado del Tratamiento
AB The incidence of malignant tumors in recipients of renal allografts is higher than in the general population. Renal cell carcinoma (RCC) accounts for 4.6% of the tumors in transplanted patients; of them, only 10% are found in transplanted kidneys. Transplantectomy has always been the usual treatment. However, during the last years, nephron-sparing surgery of the allograft is more frequently done in well-selected cases, and therefore dialysis can be avoided. We report the case of a 37-year-old female patient with renal transplant, diagnosed with a 4.5 cm tumor in the lower pole of the renal allograft. The patient underwent partial nephrectomy successfully. Six years after surgery, there is no evidence of recurrence of the disease and the patient maintains an adequate renal function.
PB Hindawi Publishing Corporation
YR 2012
FD 2012-06-21
LK http://hdl.handle.net/10668/837
UL http://hdl.handle.net/10668/837
LA en
NO Vázquez Alonso F, Cardozo Rodríguez E, Puche Sanz I, Flores Martin JF, Molina Hernandez JM, Berrio Campos R, et al. Nephron-sparing surgery for adenocarcinoma in a renal allograft. Case Rep Urol; 2012:692986
NO Journal Article;
DS RISalud
RD Apr 9, 2025